NewAmsterdam Pharma Q3 Net Loss Narrows 76% to USD 17.39 Million
The company reported a net loss of USD 17.39 million for Q3 2026, down 76% year over year.
Related stories
Southern Petrochemicals Industries Reports Q2 Net Profit of INR 470.6 Million
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Novo Nordisk CEO Says Patient Perception Is Boosting Weight-Loss Pill Growth
Novo Nordisk’s chief executive says a change in patient perception is spurring growth of the company’s weight-loss pill and bodes well for future market launches. The company launc
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Ravindra Energy Reports Q2 Consolidated Net Profit of INR 190.5 Million
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
TeraWulf Secures Google Credit Backstop for $19 Billion Anthropic Lease
TeraWulf also signed a definitive engineering, procurement and construction deal with Fluor. Google LLC, a unit of Alphabet, will provide contractual credit support for anticipated
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
CIRO Halts Trading in Anteros
The Canadian Investment Regulatory Organization halted trading in Anteros shares.
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC
Analysts Raise Estée Lauder Price Targets After Q1 Results
Several analysts raised price targets on Estée Lauder after its fiscal first-quarter results. Shares rose in premarket trading, and the company outlined financial ambitions through
M impact | EQUITY | Nov 04, 2026, 01:19 PM UTC